Overview

• Eli Lilly will lift Mounjaro’s UK wholesale price by 170% from 1 September, taking the top dose from £122 to £330 a month.
• CheqUp reported a 27-fold (2,660%) jump in Wegovy sales in a single day, with first-dose orders up 2,212% as users switch or start treatment.
• Novo Nordisk’s Wegovy is listed privately at about £85–£160 per month, and the company has not increased UK prices.
• NHS England says its commissioning price is unchanged, preserving access for eligible patients with obesity or type 2 diabetes.
• The drugs use different active ingredients—tirzepatide versus semaglutide—with clinicians noting differences that matter when switching, and media estimate more than a million UK users.